Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT1406 vs Humira in active ankylosing spondylitis
CTR20160565Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Sep 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of qletli in ankylosing spondylitis (AS), sponsored by Bio-Thera Solutions, Ltd.. Started Sep 2016; status: completed.
02
Drugs
qletli
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on CTR20160565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160565.